Drug
V0057 A
V0057 A: highest development phase Phase 1, developed by Pierre Fabre. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Pierre Fabre
Trials
| Drug | Phase | Indication |
|---|---|---|
| V0057 - A mg NCT01861626 | Phase 1 | Healthy Volunteers |
Latest
No recent events.
Follow V0057 A on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.